Speciality Medicines IPO GMP Today
The Speciality Medicines IPO GMP is ₹0 (0.0% over the upper price band of ₹124) as of 7 Oct 2026, giving an estimated listing price of ₹124 per share. On a minimum application of 2,000 shares, that is an estimated gain of ₹0.
Last updated
- Issue Price
- ₹124
- GMP
- ₹0
- GMP %
- 0.0%
- Est. listing
- ₹124
- Est. gain / application
- ₹0
Speciality Medicines IPO GMP trend
Speciality Medicines IPO GMP day-wise
No grey market activity has been reported for Speciality Medicines IPO yet. GMP usually starts trading a few days before the issue opens.
Speciality Medicines IPO subscription status
| QIB | 96.24x |
|---|---|
| bNII | 2.70x |
| sNII | 0.64x |
| Retail | 0.85x |
| Total | 2.23x |
Reading the Speciality Medicines IPO GMP
The grey market premium is the price above the issue price at which Speciality Medicines IPO shares are informally traded before listing. A GMP of ₹0 on an upper band of ₹124 suggests the shares could open around ₹124, if grey market sentiment holds until listing day.
GMP is not set by the company, the exchanges or SEBI. It moves daily with market conditions and subscription demand, and SME GMP in particular can swing sharply on low volumes. Check it together with the subscription numbers and the company's financials before applying.
A zero GMP means grey market participants currently expect little or no premium on listing.
Speciality Medicines IPO GMP: FAQs
- What is Speciality Medicines IPO GMP today?
- The latest grey market premium (GMP) for the Speciality Medicines IPO is ₹0 as of 7 October 2026, which is 0.00% over the upper price band of ₹124.
- What is the expected listing price of Speciality Medicines IPO?
- Based on the current GMP, the estimated listing price of Speciality Medicines IPO is ₹124 per share (₹124 issue price + ₹0 GMP). This is an estimate from unofficial grey market trades, not a guaranteed listing price.
- What is the lot size and minimum investment for Speciality Medicines IPO?
- The lot size is 1,000 shares. The minimum application is 2 lots (2,000 shares), which costs ₹2,48,000 at the upper price band.
- Is IPO GMP reliable?
- GMP reflects unofficial trades before listing and changes daily with market mood and subscription demand. It is a useful sentiment indicator but often differs from the actual listing price, so use it alongside the company's financials and subscription data.
GMP is an unofficial indicator compiled from grey market sources and is not investment advice. Actual listing prices can differ significantly. Read the offer document before investing.